From Wikipedia, the free encyclopedia
Rentiapril
|
|
Names
|
IUPAC name
(2R,4R)-2-(2-hydroxyphenyl)-3-(3-sulfanylpropanoyl)-1,3-thiazolidine-4-carboxylic acid
|
Identifiers
|
|
|
|
|
ChemSpider
|
|
|
|
UNII
|
|
|
|
InChI=1S/C13H15NO4S2/c15-10-4-2-1-3-8(10)12-14(11(16)5-6-19)9(7-20-12)13(17)18/h1-4,9,12,15,19H,5-7H2,(H,17,18)/t9-,12+/m0/s1 NKey: BSHDUMDXSRLRBI-JOYOIKCWSA-N NInChI=1/C13H15NO4S2/c15-10-4-2-1-3-8(10)12-14(11(16)5-6-19)9(7-20-12)13(17)18/h1-4,9,12,15,19H,5-7H2,(H,17,18)/t9-,12+/m0/s1 Key: BSHDUMDXSRLRBI-JOYOIKCWBM
|
C1[C@H](N([C@H](S1)C2=CC=CC=C2O)C(=O)CCS)C(=O)O
|
Properties
|
|
C13H15NO4S2
|
Molar mass
|
313.39 g·mol−1
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
Rentiapril is an ACE inhibitor.[1]
References
- ^ Takase K, Ikuse T, Aono H, Okahara A (January 1995). "Toxicity study of the angiotensin converting enzyme inhibitor rentiapril in rats". Arzneimittelforschung. 45 (1): 15–8. PMID 7893262.
|
---|
ATRTooltip Angiotensin receptor | |
---|
Combinations: | |
---|